BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 203425)

  • 1. Protective activity of secondary effector T cells generated in vitro against ectromelia virus infection in vivo.
    Kees U; Blanden RV
    Clin Exp Immunol; 1977 Dec; 30(3):338-46. PubMed ID: 203425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell-mediated immune response to ectromelia virus infection. Secondary response in vitro: specificity, nature of effector and responder cells and requirements for induction of antigenic changes in stimulator cells.
    Pang T; Blanden RV
    Aust J Exp Biol Med Sci; 1976 Jun; 54(3):253-64. PubMed ID: 65167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. III. In vivo protective activity of effector cells generated in vitro.
    Dunlop MB
    Immunology; 1978 Feb; 34(2):291-302. PubMed ID: 304841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.
    Zinkernagel RM; Welsh RM
    J Immunol; 1976 Nov; 117(5 Pt 1):1495-502. PubMed ID: 794412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between LCM virus-specific secondary cytotoxic T lymphocytes generated by Con A and by the homologous antigen.
    Marker O; Andersen GT
    Immunology; 1979 Oct; 38(2):235-44. PubMed ID: 315920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus II. Nature and specificity of effector cells.
    Dunlop MB; Doherty PC; Zinkernagel RM; Blanden RV
    Immunology; 1976 Aug; 31(2):181-6. PubMed ID: 1085282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
    J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex.
    Doherty PC; Zinernagel RM
    J Immunol; 1975 Jan; 114(1 Pt 1):30-3. PubMed ID: 1078677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.
    Walker CM; Paetkau V; Rawls WE; Rosenthal KL
    J Immunol; 1985 Aug; 135(2):1401-7. PubMed ID: 2989365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro primary induction of cytotoxic T cells against virus-infected syngeneic cells.
    Blanden RV; Kees U; Dunlop MB
    J Immunol Methods; 1977; 16(1):73-89. PubMed ID: 193995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T cell response to lymphocytic choriomeningitis virus. Properties of precursors of effector T cells, primary effector T cells and memory T cells in vitro and in vivo.
    Dunlop MB; Doherty PC; Zinkernagel RM; Blanden RV
    Immunology; 1977 Sep; 33(3):361-8. PubMed ID: 302823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. I. Kinetics of induction in vitro and yields of effector cells.
    Dunlop MB; Blanden RV
    Immunology; 1976 Aug; 31(2):171-80. PubMed ID: 955675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice.
    Lehmann-Grube F; Assmann U; Löliger C; Moskophidis D; Löhler J
    J Immunol; 1985 Jan; 134(1):608-15. PubMed ID: 3871115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo antiviral effect of cytotoxic T lymphocyte clones specific for lymphocytic choriomeningitis virus.
    Cihak J
    Microbiologica; 1986 Jul; 9(3):333-42. PubMed ID: 3489156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo treatment with an appropriate anti-Thy-1.2 monoclonal antibody abrogates hybrid resistance to Thy-1.1+ virus-immune effector T cells.
    Doherty PC; Allan JE; Allan W
    Immunology; 1989 Apr; 66(4):631-3. PubMed ID: 2785489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal intraepithelial lymphocytes respond to systemic lymphocytic choriomeningitis virus infection.
    Sydora BC; Jamieson BD; Ahmed R; Kronenberg M
    Cell Immunol; 1996 Feb; 167(2):161-9. PubMed ID: 8603424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of IL-12 on the response and susceptibility to experimental viral infections.
    Orange JS; Wolf SF; Biron CA
    J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells vs cytotoxic T cells in the peripheral blood of virus-infected mice.
    Stitz L; Althage A; Hengartner H; Zinkernagel R
    J Immunol; 1985 Jan; 134(1):598-602. PubMed ID: 2981094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.